{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T08:50:35Z","timestamp":1781945435316,"version":"3.54.5"},"reference-count":132,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.thromres.2025.109566","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:03:27Z","timestamp":1766189007000},"page":"109566","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Aptamer-based monitorization and therapeutic applications of blood coagulation cascade disorders: A systematic review"],"prefix":"10.1016","volume":"258","author":[{"given":"Okan","family":"Y\u0131lmaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beyza Nur","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neslihan Bet\u00fcl","family":"Kandilcik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep Sebla","family":"Yi\u011fit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mediha Esra","family":"Altuntop Yayla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.thromres.2025.109566_bb0005","doi-asserted-by":"crossref","first-page":"12563","DOI":"10.3390\/ijms241612563","article-title":"The crossroads of the coagulation system and the immune system: interactions and connections","volume":"24","author":"Wilhelm","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.thromres.2025.109566_bb0010","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/bjh.15062","article-title":"Haemostasis and innate immunity - a complementary relationship: a review of the intricate relationship between coagulation and complement pathways","volume":"180","author":"Keragala","year":"2018","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.thromres.2025.109566_bb0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.blre.2014.09.003","article-title":"Fibrinolysis and the control of blood coagulation","volume":"29","author":"Chapin","year":"2015","journal-title":"Blood Rev."},{"issue":"3","key":"10.1016\/j.thromres.2025.109566_bb0020","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.blre.2014.10.003","article-title":"Platelet secretion: from haemostasis to wound healing and beyond","volume":"29","author":"Golebiewska","year":"2015","journal-title":"Blood Rev."},{"issue":"5","key":"10.1016\/j.thromres.2025.109566_bb0025","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4103\/0019-5049.144643","article-title":"Overview of the coagulation system","volume":"58","author":"Palta","year":"2014","journal-title":"Indian J. Anaesth."},{"issue":"2","key":"10.1016\/j.thromres.2025.109566_bb0030","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1161\/CIRCRESAHA.121.319821","article-title":"Platelet and megakaryocyte roles in innate and adaptive immunity","volume":"130","author":"Koupenova","year":"2022","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.thromres.2025.109566_bb0035","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.3390\/ijms23073868","article-title":"Beyond hemostasis: platelet innate immune interactions and Thromboinflammation","volume":"23","author":"Mandel","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.thromres.2025.109566_bb0040","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s12185-016-2086-z","article-title":"Functional characterization of tissue factor in von Willebrand factor-dependent thrombus formation under whole blood flow conditions","volume":"104","author":"Matsunari","year":"2016","journal-title":"Int. J. Hematol."},{"issue":"4","key":"10.1016\/j.thromres.2025.109566_bb0045","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/ATVBAHA.109.200964","article-title":"Tissue factor-bearing microparticles and thrombus formation","volume":"31","author":"Zwicker","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2025.109566_bb0050","series-title":"StatPearls [Internet]","article-title":"Physiology, Coagulation Pathways","author":"Chaudhry","year":"2025"},{"key":"10.1016\/j.thromres.2025.109566_bb0055","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/978-3-319-49674-0_13","article-title":"Fibrin formation, structure and properties","volume":"82","author":"Weisel","year":"2017","journal-title":"Subcell. Biochem."},{"issue":"3","key":"10.1016\/j.thromres.2025.109566_bb0060","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00441-021-03471-2","article-title":"Endothelial cells and coagulation","volume":"387","author":"Neubauer","year":"2022","journal-title":"Cell Tissue Res."},{"issue":"6","key":"10.1016\/j.thromres.2025.109566_bb0065","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.12669\/pjms.306.5878","article-title":"High prevalence of protein C, protein S, antithrombin deficiency, and factor V Leiden mutation as a cause of hereditary thrombophilia in patients of venous thromboembolism and cerebrovascular accident","volume":"30","author":"Ali","year":"2014","journal-title":"Pak J Med Sci."},{"issue":"4","key":"10.1016\/j.thromres.2025.109566_bb0070","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/jcm6040045","article-title":"Diagnosis and treatment of von Willebrand disease and rare bleeding disorders","volume":"6","author":"Castaman","year":"2017","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.thromres.2025.109566_bb0075","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/FTD.0000000000000594","article-title":"Pharmacokinetic and pharmacodynamic drug monitoring of direct-acting oral anticoagulants: where do we stand?","volume":"41","author":"Wieland","year":"2019","journal-title":"Ther. Drug Monit."},{"issue":"19","key":"10.1016\/j.thromres.2025.109566_bb0080","doi-asserted-by":"crossref","first-page":"12035","DOI":"10.1021\/acs.chemrev.0c01140","article-title":"Aptamer-based detection of circulating targets for precision medicine","volume":"121","author":"Wu","year":"2021","journal-title":"Chem. Rev."},{"key":"10.1016\/j.thromres.2025.109566_bb0085","doi-asserted-by":"crossref","first-page":"9886","DOI":"10.1002\/chem.201503543","article-title":"Recent progress in aptamer-based functional probes for bioanalysis and biomedicine","volume":"22","author":"Zhang","year":"2016","journal-title":"Chem. Eur. J."},{"issue":"3","key":"10.1016\/j.thromres.2025.109566_bb0090","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrd.2016.199","article-title":"Aptamers as targeted therapeutics: current potential and challenges","volume":"16","author":"Zhou","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.thromres.2025.109566_bb0095","doi-asserted-by":"crossref","first-page":"0076","DOI":"10.1038\/s41570-017-0076","article-title":"Analysis of aptamer discovery and technology","volume":"1","author":"Dunn","year":"2017","journal-title":"Nat. Rev. Chem."},{"key":"10.1016\/j.thromres.2025.109566_bb0100","article-title":"Revolutionizing biomedicine: aptamer-based nanomaterials and nanodevices for therapeutic applications","volume":"42","author":"Urmi","year":"2024","journal-title":"Biotechnol. Rep. (Amst.)"},{"issue":"14","key":"10.1016\/j.thromres.2025.109566_bb0105","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1039\/D0AN00178C","article-title":"Aptamers vs. antibodies as capture probes in optical porous silicon biosensors","volume":"145","author":"Arshavsky-Graham","year":"2020","journal-title":"Analyst"},{"issue":"6","key":"10.1016\/j.thromres.2025.109566_bb0110","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1515\/cclm-2016-0381","article-title":"Point-of-care testing INR: an overview","volume":"55","author":"Barcellona","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"issue":"1","key":"10.1016\/j.thromres.2025.109566_bb0115","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/jth.13879","article-title":"International collaborative study for the calibration of proposed international standards for thromboplastin, rabbit, plain, and for thromboplastin, recombinant, human, plain","volume":"16","author":"van den Besselaar","year":"2018","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2025.109566_bb0120","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1309\/AJCPGTCEX7K4GXQO","article-title":"Comparison of the aPTT with alternative tests for monitoring direct thrombin inhibitors in patient samples","volume":"141","author":"Lind","year":"2014","journal-title":"Am. J. Clin. Pathol."},{"issue":"5","key":"10.1016\/j.thromres.2025.109566_bb0125","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1111\/bjh.15978","article-title":"Utility of fibrinogen in the coagulation screen","volume":"186","author":"Tham","year":"2019","journal-title":"Br. J. Haematol."},{"issue":"10","key":"10.1016\/j.thromres.2025.109566_bb0130","doi-asserted-by":"crossref","first-page":"938","DOI":"10.5858\/arpa.2024-0399-OA","article-title":"Clinical evaluation of the heparin therapeutic window using activated clotting time in neurological interventional radiology at an Academic Medical Center","volume":"149","author":"Nelson","year":"2025","journal-title":"Arch Pat Lab."},{"key":"10.1016\/j.thromres.2025.109566_bb0135","doi-asserted-by":"crossref","DOI":"10.1080\/10408363.2018.1529734","article-title":"D-dimer: preanalytical, analytical, postanalytical variables, and clinical applications","volume":"55","author":"Favresse","year":"2018","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"8","key":"10.1016\/j.thromres.2025.109566_bb0140","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.3390\/jcm9082636","article-title":"Advances in platelet function testing\u2014light transmission Aggregometry and beyond","volume":"9","author":"Blanc","year":"2020","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.thromres.2025.109566_bb0145","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/ajcp\/aqv022","article-title":"Harmonizing the international normalized ratio (INR): standardization of methods and use of novel strategies to reduce interlaboratory variation and bias","volume":"145","author":"Favaloro","year":"2016","journal-title":"Am. J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.thromres.2025.109566_bb0150","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/ijlh.13349","article-title":"Standardization of prothrombin time\/international normalized ratio (PT\/INR)","volume":"43","author":"Dorgalaleh","year":"2021","journal-title":"Int. J. Lab. Hematol."},{"issue":"2","key":"10.1016\/j.thromres.2025.109566_bb0155","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0022-2143(96)90014-1","article-title":"Reliability of the international normalized ratio for monitoring the induction phase of warfarin: comparison with the prothrombin time ratio","volume":"128","author":"Johnston","year":"1996","journal-title":"J. Lab. Clin. Med."},{"issue":"20","key":"10.1016\/j.thromres.2025.109566_bb0160","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood.2020008698","article-title":"Ignoring instead of chasing after coagulation factor VII during warfarin management: an interrupted time series study","volume":"137","author":"Oskarsdottir","year":"2021","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.thromres.2025.109566_bb0165","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/jhm.2528","article-title":"Predictors of warfarin-associated adverse events in hospitalized patients: opportunities to prevent patient harm","volume":"11","author":"Metersky","year":"2016","journal-title":"J. Hosp. Med."},{"key":"10.1016\/j.thromres.2025.109566_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2023.115755","article-title":"Foldable low-cost point-of-care device for testing blood coagulation using smartphones","volume":"242","author":"Xu","year":"2023","journal-title":"Biosens. Bioelectron."},{"issue":"3","key":"10.1016\/j.thromres.2025.109566_bb0175","doi-asserted-by":"crossref","first-page":"183","DOI":"10.5152\/EurJTher.2018.602","article-title":"Effects of regular follow-up on quality of life and warfarin efficiency in rural patients","volume":"25","author":"K\u0131l\u0131\u00e7","year":"2023","journal-title":"Eur J Ther."},{"issue":"5","key":"10.1016\/j.thromres.2025.109566_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102470","article-title":"Interference of lupus anticoagulant causing antiprothrombin and anti-beta-2-glycoprotein I antibodies on international normalized ratio measurements: comparative analysis of international normalized ratio methods","volume":"8","author":"Gehlen","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"issue":"6","key":"10.1016\/j.thromres.2025.109566_bb0185","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.121.007956","article-title":"Drug interactions affecting oral anticoagulant use","volume":"15","author":"Mar","year":"2022","journal-title":"Circ. Arrhythm. Electrophysiol."},{"issue":"1","key":"10.1016\/j.thromres.2025.109566_bb0190","doi-asserted-by":"crossref","first-page":"1700047","DOI":"10.1002\/biot.201700047","article-title":"Microfluidics based point-of-care diagnostics","volume":"13","author":"Augustine","year":"2018","journal-title":"Biotechnol. J."},{"issue":"24","key":"10.1016\/j.thromres.2025.109566_bb0195","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMsb1214197","article-title":"How point-of-care testing could drive innovation in global health","volume":"368","author":"Jani","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2025.109566_bb0200","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1136\/sti.2006.024265","article-title":"Rapid tests for sexually transmitted infections (STIs): the way forward","volume":"82","author":"Peeling","year":"2006","journal-title":"Sex. Transm. Infect."},{"issue":"8","key":"10.1016\/j.thromres.2025.109566_bb0205","first-page":"757","article-title":"Aptamer-based point-of-care devices: emerging technologies and integration of computational methods","volume":"13","author":"Chowdhury","year":"2023","journal-title":"Biosensors (Basel)."},{"issue":"9","key":"10.1016\/j.thromres.2025.109566_bb0215","doi-asserted-by":"crossref","first-page":"513","DOI":"10.4155\/bio-2023-0058","article-title":"Nucleic acid aptamer-based biosensors and their application in thrombin analysis","volume":"15","author":"Dong","year":"2023","journal-title":"Bioanalysis"},{"key":"10.1016\/j.thromres.2025.109566_bb0220","article-title":"Aptamer biosensors for thrombin","volume":"565","author":"Roudsari","year":"2025","journal-title":"Clin. Chim. Acta"},{"issue":"14","key":"10.1016\/j.thromres.2025.109566_bb0225","article-title":"Sandwich-type aptamer-based biosensors for thrombin detection","volume":"16","author":"Samani","year":"2024","journal-title":"Anal. Methods"},{"issue":"7","key":"10.1016\/j.thromres.2025.109566_bb0230","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3390\/chemosensors10070255","article-title":"Aptamer-based sensors for thrombin detection application","volume":"10","author":"Sun","year":"2022","journal-title":"Chemosensors"},{"key":"10.1016\/j.thromres.2025.109566_bb0235","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.omtn.2023.01.009","article-title":"Rapid molecular imaging of active thrombi in vivo using aptamer-antidote probes","volume":"31","author":"Gray","year":"2023","journal-title":"Mol Ther Nucleic Acids."},{"key":"10.1016\/j.thromres.2025.109566_bb0240","series-title":"Integration of Thrombin-Binding Aptamers in Point-of-Care Devices for Continuous Monitoring of Thrombin in Plasma","author":"Trapaidze","year":"2015"},{"key":"10.1016\/j.thromres.2025.109566_bb0245","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.talanta.2015.05.034","article-title":"An aptamer-based single particle method for sensitive detection of thrombin using fluorescent quantum dots as labeling probes","volume":"144","author":"Yin","year":"2015","journal-title":"Talanta"},{"issue":"45","key":"10.1016\/j.thromres.2025.109566_bb0250","doi-asserted-by":"crossref","first-page":"6010","DOI":"10.1002\/adma.201201484","article-title":"Aptamer-crosslinked microbubbles: smart contrast agents for thrombin-activated ultrasound imaging","volume":"24","author":"Nakatsuka","year":"2012","journal-title":"Adv. Mater."},{"issue":"48","key":"10.1016\/j.thromres.2025.109566_bb0255","doi-asserted-by":"crossref","first-page":"17225","DOI":"10.1021\/jacs.7b07913","article-title":"DNA aptamer-based activatable probes for photoacoustic imaging in living mice","volume":"139","author":"Zhang","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.thromres.2025.109566_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2023.122615","article-title":"A fluorescence biosensor based on DNA aptamers-COF for highly selective detection of ATP and thrombin","volume":"295","author":"Jouha","year":"2023","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"issue":"12","key":"10.1016\/j.thromres.2025.109566_bb0265","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1021\/acs.bioconjchem.0c00525","article-title":"Assessment of aptamer-targeted contrast agents for monitoring of blood clots in computed tomography and fluoroscopy imaging","volume":"31","author":"Koudrina","year":"2020","journal-title":"Bioconjug. Chem."},{"issue":"8","key":"10.1016\/j.thromres.2025.109566_bb0270","doi-asserted-by":"crossref","first-page":"9412","DOI":"10.1021\/acsami.0c16666","article-title":"Exploring the unique contrast properties of aptamer\u2013gadolinium conjugates in magnetic resonance imaging for targeted imaging of thrombi","volume":"13","author":"Koudrina","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"2","key":"10.1016\/j.thromres.2025.109566_bb0275","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.pharma.2024.08.005","article-title":"Cardiovascular disease and thrombosis: intersections with the immune system, inflammation, and the coagulation system","volume":"83","author":"Rajput","year":"2025","journal-title":"Ann. Pharm. Fr."},{"key":"10.1016\/j.thromres.2025.109566_bb0280","series-title":"StatPearls","article-title":"Anticoagulation Safety","author":"Amaraneni","year":"2025"},{"key":"10.1016\/j.thromres.2025.109566_bb0285","doi-asserted-by":"crossref","first-page":"1002285","DOI":"10.3389\/fbioe.2022.1002285","article-title":"Aptamer-based applications for cardiovascular disease","volume":"10","author":"Chen","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"8","key":"10.1016\/j.thromres.2025.109566_bb0290","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.3390\/ijms22083897","article-title":"Overview of the therapeutic potential of aptamers targeting coagulation factors","volume":"22","author":"Liu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.thromres.2025.109566_bb0295","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1161\/ATVBAHA.115.300131","article-title":"Modulation of the coagulation cascade using aptamers","volume":"35","author":"Woodruff","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.thromres.2025.109566_bb0300","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/MBC.0000000000001130","article-title":"The role of thrombin in haemostasis","volume":"33","author":"Al-Amer","year":"2022","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"19","key":"10.1016\/j.thromres.2025.109566_bb0305","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910803","article-title":"Exosite binding in thrombin: a global structural\/dynamic overview of complexes with aptamers and other ligands","volume":"22","author":"Troisi","year":"2021","journal-title":"In. J Mol Sci"},{"issue":"12","key":"10.1016\/j.thromres.2025.109566_bb0310","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1261\/rna.1240109","article-title":"Synergistic effect of aptamers that inhibit exosites 1 and 2 on thrombin","volume":"15","author":"Nimjee","year":"2009","journal-title":"RNA"},{"issue":"6360","key":"10.1016\/j.thromres.2025.109566_bb0315","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/355564a0","article-title":"Selection of single-stranded DNA molecules that bind and inhibit human thrombin","volume":"355","author":"Bock","year":"1992","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.thromres.2025.109566_bb0320","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1111\/j.1538-7836.2008.03162.x","article-title":"Anticoagulant characteristics of HD1-22, a bivalent aptamer that specifically inhibits thrombin and prothrombinase","volume":"6","author":"M\u00fcller","year":"2008","journal-title":"J. Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.thromres.2025.109566_bb0325","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1517\/13543784.2013.821463","article-title":"Investigational anticoagulants for hematological conditions: a new generation of therapies","volume":"22","author":"Denas","year":"2013","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"11","key":"10.1016\/j.thromres.2025.109566_bb0330","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.3390\/ijms21113860","article-title":"Design, synthesis and characterization of cyclic NU172 analogues: a biophysical and biological insight","volume":"21","author":"Riccardi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.thromres.2025.109566_bb0335","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1021\/ja043285e","article-title":"Light regulation of aptamer activity: an anti-thrombin aptamer with caged thymidine nucleobases","volume":"127","author":"Heckel","year":"2005","journal-title":"J. Am. Chem. Soc."},{"issue":"11","key":"10.1016\/j.thromres.2025.109566_bb0340","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.thromres.2025.109566_bb0345","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"ENGAGE AF-TIMI 48 Investigators. Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.thromres.2025.109566_bb0350","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.1074\/jbc.M109.049833","article-title":"An anticoagulant RNA aptamer that inhibits proteinase-cofactor interactions within prothrombinase","volume":"285","author":"Buddai","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.thromres.2025.109566_bb0355","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nbt.4153","article-title":"Combination of aptamer and drug for reversible anticoagulation in cardiopulmonary bypass","volume":"36","author":"Gunaratne","year":"2018","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.thromres.2025.109566_bb0360","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.chembiol.2022.01.009","article-title":"Generation of an anticoagulant aptamer that targets factor V\/Va and disrupts the FVa-membrane interaction in normal and COVID-19 patient samples","volume":"29","author":"Soule","year":"2022","journal-title":"Cell Chem. Bio."},{"issue":"4","key":"10.1016\/j.thromres.2025.109566_bb0365","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3390\/jcm10040677","article-title":"Functional and structural characterization of nucleic acid ligands that bind to activated coagulation factor XIII","volume":"10","author":"Hamedani","year":"2021","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.thromres.2025.109566_bb0370","first-page":"841","article-title":"Blocking the initiation of coagulation by RNA aptamers to factor VIIa","volume":"84","author":"Rusconi","year":"2000","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2025.109566_bb0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/oli.2006.0059","article-title":"Simultaneous generation of aptamers to multiple gamma-carboxyglutamic acid proteins from a focused aptamer library using DeSELEX and convergent selection","volume":"17","author":"Layzer","year":"2007","journal-title":"Oligonucleotides"},{"issue":"16","key":"10.1016\/j.thromres.2025.109566_bb0380","doi-asserted-by":"crossref","first-page":"12779","DOI":"10.1074\/jbc.M111.300772","article-title":"Potent anticoagulant aptamer directed against factor IXa blocks macromolecular substrate interaction","volume":"287","author":"Sullenger","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"6902","key":"10.1016\/j.thromres.2025.109566_bb0385","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature00963","article-title":"RNA aptamers as reversible antagonists of coagulation factor IXa","volume":"419","author":"Rusconi","year":"2002","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.thromres.2025.109566_bb0390","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nbt1023","article-title":"Antidote-mediated control of an anticoagulant aptamer in vivo","volume":"22","author":"Rusconi","year":"2004","journal-title":"Nat. Biotechnol."},{"issue":"22","key":"10.1016\/j.thromres.2025.109566_bb0395","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1161\/CIRCULATIONAHA.107.745687","article-title":"Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease","volume":"117","author":"Chan","year":"2008","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.thromres.2025.109566_bb0400","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1161\/CIRCULATIONAHA.106.668434","article-title":"First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activity","volume":"114","author":"Dyke","year":"2006","journal-title":"Circulation"},{"issue":"31","key":"10.1016\/j.thromres.2025.109566_bb0405","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1093\/eurheartj\/ehs232","article-title":"A phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial","volume":"34","author":"Povsic","year":"2013","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.thromres.2025.109566_bb0410","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/j.jaci.2016.04.058","article-title":"Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer","volume":"138","author":"Povsic","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"10016","key":"10.1016\/j.thromres.2025.109566_bb0415","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0140-6736(15)00515-2","article-title":"Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial","volume":"387","author":"Lincoff","year":"2016","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.thromres.2025.109566_bb0420","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/j.1538-7836.2012.04742.x","article-title":"A phase 1 ascending dose study of a subcutaneously administered factor IXa inhibitor and its active control agent","volume":"10","author":"Vavalle","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109566_bb0425","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.thromres.2017.10.008","article-title":"An update on factor XI structure and function","volume":"161","author":"Mohammed","year":"2018","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2025.109566_bb0430","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1038\/s41598-017-02055-x","article-title":"Selection and characterization of a DNA aptamer inhibiting coagulation factor XIa","volume":"7","author":"Donkor","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.thromres.2025.109566_bb0435","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.thromres.2017.06.015","article-title":"Generation and characterization of aptamers targeting factor XIa","volume":"156","author":"Woodruff","year":"2017","journal-title":"Thromb. Res."},{"issue":"7","key":"10.1016\/j.thromres.2025.109566_bb0440","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/jth.12302","article-title":"Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer","volume":"11","author":"Woodruff","year":"2013","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2025.109566_bb0445","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.3390\/jcm14051647","article-title":"Anticoagulation management: current landscape and future trends","volume":"14","author":"Kholmukhamedov","year":"2025","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.thromres.2025.109566_bb0450","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrd3141","article-title":"Aptamers as therapeutics","volume":"9","author":"Keefe","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.thromres.2025.109566_bb0455","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.addr.2018.08.005","article-title":"Aptamer-based targeted therapy","volume":"134","author":"Zhu","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.thromres.2025.109566_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2025.101350","article-title":"The recent blooming of therapeutic aptamers","volume":"102","author":"Cesarini","year":"2025","journal-title":"Mol. Asp. Med."},{"issue":"17","key":"10.1016\/j.thromres.2025.109566_bb0465","first-page":"4920","article-title":"Smart aptamer-based nanodevices for clinical applications","volume":"49","author":"Li","year":"2020","journal-title":"Chem. Soc. Rev."},{"issue":"80","key":"10.1016\/j.thromres.2025.109566_bb0470","doi-asserted-by":"crossref","first-page":"10472","DOI":"10.1039\/c2cc35042d","article-title":"Nucleic acid aptamers: an emerging frontier in cancer therapy","volume":"48","author":"Zhu","year":"2012","journal-title":"Chem. Commun."},{"issue":"4","key":"10.1016\/j.thromres.2025.109566_bb0475","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1021\/cr300468w","article-title":"Aptamers from cell-based selection for bioanalytical applications","volume":"113","author":"Tan","year":"2013","journal-title":"Chem. Rev."},{"issue":"46","key":"10.1016\/j.thromres.2025.109566_bb0480","doi-asserted-by":"crossref","first-page":"16442","DOI":"10.1021\/jacs.7b07799","article-title":"Micellar thrombin-binding aptamers: reversible nanoscale anticoagulants","volume":"139","author":"Roloff","year":"2017","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.thromres.2025.109566_bb0485","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/btpr.2524","article-title":"Biophysical characterization of layer-by-layer synthesis of aptamer-drug microparticles for enhanced cell targeting","volume":"34","author":"Tan","year":"2018","journal-title":"Biotechnol. Prog."},{"issue":"23","key":"10.1016\/j.thromres.2025.109566_bb0490","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.3390\/s19235260","article-title":"Thrombin aptamer-modified metal\u2013organic framework nanoparticles: functional nanostructures for sensing thrombin and the triggered controlled release of anti-blood clotting drugs","volume":"19","author":"Chen","year":"2019","journal-title":"Sensors (Basel)."},{"issue":"40","key":"10.1016\/j.thromres.2025.109566_bb0495","doi-asserted-by":"crossref","first-page":"17697","DOI":"10.1002\/anie.202007962","article-title":"An intelligent DNA nanorobot for autonomous anticoagulation","volume":"59","author":"Yang","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.thromres.2025.109566_bb0500","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/s41563-024-01826-y","article-title":"An intelligent DNA nanodevice for precision thrombolysis","volume":"23","author":"Yin","year":"2024","journal-title":"Nat. Mater."},{"key":"10.1016\/j.thromres.2025.109566_bb0505","article-title":"Protein\u2013protein communication mediated by an antibody-responsive DNA nanodevice","volume":"61","author":"Ranallo","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"issue":"3","key":"10.1016\/j.thromres.2025.109566_bb0510","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/nbt.4071","article-title":"A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo","volume":"36","author":"Li","year":"2018","journal-title":"Nat. Biotechnol."},{"issue":"7","key":"10.1016\/j.thromres.2025.109566_bb0515","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.apsb.2020.11.014","article-title":"Molecularly engineered truncated tissue factor with therapeutic aptamers for tumor-targeted delivery and vascular infarction","volume":"11","author":"Li","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"5","key":"10.1016\/j.thromres.2025.109566_bb0520","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.chembiol.2019.02.001","article-title":"Anti-PEG antibodies inhibit the anticoagulant activity of PEGylated aptamers","volume":"26","author":"Moreno","year":"2019","journal-title":"Cell Chem. Biol."},{"issue":"4","key":"10.1016\/j.thromres.2025.109566_bb0525","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3390\/molecules21040421","article-title":"Methods for improving aptamer binding affinity","volume":"21","author":"Hasegawa","year":"2016","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.thromres.2025.109566_bb0530","doi-asserted-by":"crossref","first-page":"9500","DOI":"10.1021\/acsami.0c05750","article-title":"Recent progress in aptamer discoveries and modifications for therapeutic applications","volume":"13","author":"Ni","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.thromres.2025.109566_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.snb.2024.136811","article-title":"Gold nanoprism enhanced SERS aptasensor for simultaneous detection of thrombin and VEGF","volume":"423","author":"Anantha","year":"2025","journal-title":"Sensors Actuators B Chem."},{"issue":"26","key":"10.1016\/j.thromres.2025.109566_bb0540","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"EINSTEIN Investigators. Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"Bauersachs","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2025.109566_bb0545","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.talanta.2018.08.048","article-title":"Design of an aptamer-based magnetic adsorbent and biosensor systems for selective and sensitive separation and detection of thrombin","volume":"191","author":"Bayramoglu","year":"2019","journal-title":"Talanta"},{"key":"10.1016\/j.thromres.2025.109566_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2025.117132","article-title":"Ultrasensitive dual-mode biosensor for photoelectrochemical and differential pulse voltammetry detection of thrombin based on DNA self-assembly","volume":"272","author":"Bi","year":"2025","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.thromres.2025.109566_bb0555","doi-asserted-by":"crossref","first-page":"18740","DOI":"10.1038\/s41598-019-55248-x","article-title":"D-shaped plastic optical fibre aptasensor for fast thrombin detection in nanomolar range","volume":"9","author":"Cennamo","year":"2019","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.thromres.2025.109566_bb0560","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3390\/bios14060270","article-title":"Development of an aptamer-based QCM-D biosensor for the detection of thrombin using supported lipid bilayers as surface functionalization","volume":"14","author":"G\u00f6rner","year":"2024","journal-title":"Biosensors"},{"key":"10.1016\/j.thromres.2025.109566_bb0565","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.nanoen.2016.09.039","article-title":"Self-powered triboelectric aptasensor for label-free highly specific thrombin detection","volume":"30","author":"Jung","year":"2016","journal-title":"Nano Energy"},{"key":"10.1016\/j.thromres.2025.109566_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2024.116184","article-title":"Electrochemical biosensor using direct electron transfer and an antibody\u2013aptamer hybrid sandwich for target detection in complex biological samples","volume":"253","author":"Kim","year":"2024","journal-title":"Biosens. Bioelectron."},{"issue":"7","key":"10.1016\/j.thromres.2025.109566_bb0575","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1039\/C5TB02032H","article-title":"Three label-free thrombin aptasensors based on aptamers and [Ru(bpy)\u2082(o-mopip)]2+","volume":"4","author":"Li","year":"2016","journal-title":"J. Mater. Chem. B"},{"issue":"4","key":"10.1016\/j.thromres.2025.109566_bb0580","doi-asserted-by":"crossref","DOI":"10.1149\/1945-7111\/ad39a9","article-title":"A three-dimensional AgNPs\/TiO\u2082\/Ti\u2083C\u2082T\u2093 composite for label-free thrombin aptamer sensor","volume":"171","author":"Li","year":"2024","journal-title":"J. Electrochem. Soc."},{"key":"10.1016\/j.thromres.2025.109566_bb0585","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.saa.2017.10.074","article-title":"A chemiluminescence biosensor for the detection of thrombin based on the aptamer composites","volume":"192","author":"Lin","year":"2018","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.thromres.2025.109566_bb0590","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.snb.2017.11.083","article-title":"Ultrasensitive detection of thrombin based on MoS\u2082-aptamer biosensors by resonance light scattering technique","volume":"258","author":"Liu","year":"2018","journal-title":"Sensors Actuators B Chem."},{"key":"10.1016\/j.thromres.2025.109566_bb0595","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.aca.2015.09.051","article-title":"Label-free aptamer biosensor for selective detection of thrombin","volume":"899","author":"Na","year":"2015","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.thromres.2025.109566_bb0600","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41427-022-00443-y","article-title":"Aptamer-functionalized smart photonic hydrogels: application for the detection of thrombin in human serum","volume":"14","author":"Shen","year":"2022","journal-title":"NPG Asia Mater."},{"issue":"23","key":"10.1016\/j.thromres.2025.109566_bb0605","doi-asserted-by":"crossref","DOI":"10.1063\/1.4937351","article-title":"Thrombin detection in murine plasma using engineered fluorescence resonance energy transfer aptadimers","volume":"107","author":"Trapaidze","year":"2015","journal-title":"Appl. Phys. Lett."},{"issue":"3","key":"10.1016\/j.thromres.2025.109566_bb0610","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/00032719.2023.2209678","article-title":"Sensitive and selective electrochemical determination of thrombin as a peptide biomarker by a multiwalled carbon nanotube (MWCNT)\/aptamer\/molecularly imprinted polymer (MIP)-based biosensor","volume":"57","author":"Turk","year":"2023","journal-title":"Anal. Lett."},{"key":"10.1016\/j.thromres.2025.109566_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.snb.2025.137977","article-title":"Electrochemical aptasensor for thrombin based on polyfunctionalized dendritic nanodevice as natural enzyme-free labeling element","volume":"441","author":"Villalonga","year":"2025","journal-title":"Sensors Actuators B Chem."},{"issue":"21","key":"10.1016\/j.thromres.2025.109566_bb0620","doi-asserted-by":"crossref","first-page":"8130","DOI":"10.1021\/ac201631b","article-title":"Aptamer biosensor based on fluorescence resonance energy transfer from upconverting phosphors to carbon nanoparticles for thrombin detection in human plasma","volume":"83","author":"Wang","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.thromres.2025.109566_bb0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.151224","article-title":"Single aptamer hairpin DNA-based response system combined with COF-based signal amplification strategy for ultrasensitive detection of cancer-associated thrombin","volume":"489","author":"Wang","year":"2024","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.thromres.2025.109566_bb0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2024.342494","article-title":"An electrochemical biosensor for the amplification of thrombin activity by perylene-mediated photoinitiated polymerization","volume":"1302","author":"Yu","year":"2024","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.thromres.2025.109566_bb0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2024.112048","article-title":"Ultra-sensitive immobilization-free homogeneous electrochemiluminescence biosensor for thrombin detection via electrostatic interaction and Exo I-powered signal amplification","volume":"207","author":"Zheng","year":"2024","journal-title":"Microchem. J."},{"key":"10.1016\/j.thromres.2025.109566_bb0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2020.121480","article-title":"Streaming-enhanced, chip-based biosensor with acoustically active, biomarker-functionalized micropillars: a case study of thrombin detection","volume":"222","author":"Zhou","year":"2021","journal-title":"Talanta"},{"key":"10.1016\/j.thromres.2025.109566_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2023.342106","article-title":"CRISPR\/Cas12a linked sandwich aptamer assay for sensitive detection of thrombin","volume":"1287","author":"Zhu","year":"2024","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.thromres.2025.109566_bb0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2025.113835","article-title":"A cascade signal amplification aptasensor based on the cis- and trans-cleavage activities of Cas12a for sensitive detection of thrombin","volume":"213","author":"Zong","year":"2025","journal-title":"Microchem. J."},{"key":"10.1016\/j.thromres.2025.109566_bb0655","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1038\/mtna.2014.32","article-title":"Oligonucleotide aptamers: new tools for targeted cancer therapy","volume":"3","author":"Sun","year":"2014","journal-title":"Mol. Ther. Nucleic Acids."},{"issue":"10","key":"10.1016\/j.thromres.2025.109566_bb0660","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.bios.2004.09.007","article-title":"Monitoring complex formation in the blood-coagulation cascade using aptamer-coated SAW sensors","volume":"20","author":"Gronewold","year":"2005","journal-title":"Biosens. Bioelectron."},{"issue":"1","key":"10.1016\/j.thromres.2025.109566_bb0665","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.elecom.2008.10.024","article-title":"An aptamer-based biosensor for sensitive thrombin detection","volume":"11","author":"Yang","year":"2009","journal-title":"Electrochem. Commun."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825003160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825003160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T08:16:58Z","timestamp":1781943418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384825003160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":132,"alternative-id":["S0049384825003160"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109566","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aptamer-based monitorization and therapeutic applications of blood coagulation cascade disorders: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109566","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109566"}}